老年高血压性心脏病室性心律失常应用美托洛尔的治疗效果探究

Study on the Therapeutic Effect of Metoprolol on Ventricular Arrhythmia in Elderly Patients with Hypertensive Heart Disease

目的:探究美托洛尔治疗老年高血压性心脏病室性心律失常的临床疗效。方法:选择老年高血压性心脏病室性心律失常患者80例,均为2020年7月至2021年7月收治,患者被随机数字法均分两组,常规治疗40例记为对照组,美托洛尔治疗40例记为试验组,比较临床疗效、血压、不良反应。结果:试验组临床疗效为95.00%,高于对照组的80.00%,差异显著(P<0.05)。舒张压、收缩压治疗前组间比较无显著差异(P>0.05),治疗后舒张压、收缩压降低,试验组显著低于对照组(P<0.05)。试验组不良反应发生率为7.50%,高于对照组的5.00%,但差异不显著(P>0.05)。结论:应用美托洛尔进行老年高血压性心脏病室性心律失常临床治疗效果理想,可显著降低血压,用药安全。

Objective:To explore the clinical efficacy of metoprolol in the treatment of ventricular arrhythmia in elderly patients with hypertensive heart disease.Methods:A total of 80 elderly patients with hypertensive heart disease and ventricular arrhythmia were selected,and they were all admitted from July 2020 to July 2021.The patients were divided into two groups by random number method.40 cases treated with lorol were recorded as the experimental group,and the clinical efficacy,blood pressure and adverse reactions were compared.Results:The clinical efficacy of the experimental group was 95.00%,which was higher than that of the control group,80.00%,with a significant difference(P<0.05).There was no significant difference in diastolic blood pressure and systolic blood pressure between the groups before treatment(P>0.05).The incidence of adverse reactions in the experimental group was 7.50%,which was higher than 5.00%in the control group,but the difference was not significant(P>0.05).Conclusion:The clinical effect of metoprolol in the treatment of ventricular arrhythmia in elderly patients with hypertensive heart disease is ideal,it can significantly reduce blood pressure,and the drug is safe.